Evidence map›Paper›PMID 42771849›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2026

[Acute pancreatitis as first manifestation of systemic lupus erythematosus].

Leonardo Flores-Herrera, Oscar Vidal-Santos, Gabriel Ezequiel Galindo-Magaña, Daniela Hernández-Islas

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Leonardo Flores-HerreraInstituto Mexicano del Seguro Social, Hospital General de Zona No. 47 "Vicente Guerrero", Servicio de Medicina Interna. Ciudad de México, México.ORCID 0009-0005-3852-7785
Oscar Vidal-SantosInstituto Mexicano del Seguro Social, Hospital General de Zona No. 47 "Vicente Guerrero", Servicio de Medicina Interna. Ciudad de México, México.ORCID 0009-0001-3922-6408
Gabriel Ezequiel Galindo-MagañaInstituto Mexicano del Seguro Social, Hospital General de Zona No. 47 "Vicente Guerrero", Servicio de Medicina Interna. Ciudad de México, México.ORCID 0009-0000-8781-3968
Daniela Hernández-IslasInstituto Mexicano del Seguro Social, Hospital General de Zona No. 47 "Vicente Guerrero", Servicio de Medicina Interna. Ciudad de México, México.ORCID 0009-0002-6523-7917

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease with a broad clinical spectrum; gastrointestinal involvement can occur at any stage. SLE-associated pancreatitis is infrequent and exceptional as an initial manifestation, but it is associated with high morbidity and mortality. The objective was to describe a case of severe acute pancreatitis as the initial presentation of SLE and highlight its diagnostic and prognostic relevance. Case report: A 22-year-old female with no significant medical history and a history of inflammatory arthralgia was admitted for intense abdominal pain and intractable vomiting. Acute pancreatitis was documented, progressing to severe necrotizing pancreatitis (Balthazar E), complicated by respiratory failure and admission to the intensive care unit. Given the absence of common risk factors and the presence of hemolytic anemia, a thorough immunological workup was performed, confirming autoimmunity with positive antinuclear and anti-dsDNA antibodies, diagnosing de novo SLE. Patient received high doses of corticosteroid treatment and immunosuppressive therapy, with a favorable clinical outcome. Conclusions: Lupus pancreatitis is a marker of high systemic activity and severity, often underestimated by indices such as SLEDAI. Its timely recognition is fundamental to optimize the prognosis, requiring a multidisciplinary approach with early intensive support and immunosuppressive treatment.

Indexed as

Lupus Erythematosus, SystemicPancreatitisPancreatitis, Acute NecrotizingAcute DiseaseFemaleHumansYoung AdultAutoimmune DiseasesCritical IllnessEnfermedad CríticaEnfermedades AutoinmunesLupus Eritematoso SistémicoPancreatitisSystemic Lupus Erythematosus

Identifiers

PMID42771849
PMCPMC13614670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.